App-Quantinova.ai

Determining the Efficacy of Different Double Antiplatelet Strategies Using Platelet Aggregometer in Patient Admitted with Acute Coronary Syndrome

MUHAMAD RAZI ZULKUFLI - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Midterm Clinical Outcomes After Elective Drug-Coated Balloon Dilation Versus Drug-Eluting Stents Placement for De Novo Stenosis in Large Vessel: A Single-Center Retrospective Study

Taro Takeyama - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Midterm Clinical Outcomes After Emergent Drug-Coated Balloon Dilation Versus Drug-Eluting Stents Placement for Acute Coronary Syndrome: A Single-Center Retrospective Study

Hideyuki Aoki - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Predictors and Impact of Leaflet Thrombosis Following TAVI with 320-Multislice CT at Medium Term Follow-Up

Hashrul Rashid - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Calcified Nodule as Assessed by Optical Coherence Tomography on Clinical Prognosis After 2nd Generation Drug Eluting Stent Implantation

Tetsumin Lee - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The External Validity of the DAPT Score to Guide Antiplatelet Duration After Coronary Stenting in an Unrestricted Real-World Population

Haoyu Wang - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Transcatheter Treatment of Acute Thrombosis and Embolism of Superior Mesenteric Artery

Dmitriy Vladimirovich Ovcharenko - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in Relation to High Bleeding Risk Among Patients Receiving Drug-Eluting Stents: A Large Single-Center Cohort Study

Haoyu Wang - Angioplasty Summit-TCTAP , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A lncRNA MEG9 protects vasculature from DNA damage

Cristina Espinosa-Diez - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

5-Azacytidine

LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment

S. Ogasawara - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Pembrolizumab

HGCSG1801: A phase II trial of 2nd-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibody

Y. Shindo - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

L-leucovorin

Khorana and PROTECHT scores in predicting the risk of venous thromboembolism in pancreatic cancer: Which performed better?

S. Dmaso - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1

B. Sangro - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Bevacizumab

Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel

E. Saka Topcuoglu - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Carbidopa and Levodopa

IDH MUTATION STATUS AND THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN ASTROCYTOMA PATIENTS

Jacob Mandel - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

IMPLICATION OF D-DIMER IN THE DETECTION OF DEEP VENOUS THROMBOSIS (DVT) /PULMONARY EMBOLISM (PE) IN HIGH GRADE GLIOMA PATIENTS WITHOUT CLASSIC SYMPTOMS OF DVT/PE ON OR OFF AVASTIN TREATMENT

Ruchika Jha - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Warfarin

Evidences of new risk factors for retinal vein thrombosis

M. Fruschelli - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

One-year Outcome After PCI in Patients Treated Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers - Subanalysis From Multicenter Registry -

Inagaki YUSUKE - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Angiotensin II

An Atypical Presentation of Spontaneous Coronary Artery Dissection in a Young Male Patient

Farhad Sami - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Chest Pain and Inflammation: A Story Where Hickam’s Dictum Prevailed

Kris Kumar - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Colchicine

Filters

7277 Abstracts